Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past …
vaccines, focusing on vaccine coverage and efficacy. In addition, pan-gender vaccination …

… Vaccination Impact Study Group. Population-level impact and herd effects following the
introduction of human papillomavirus vaccination … human papillomavirus prophylactic vaccines. …

… A 90-70-90 target has been set: 90% of girls should be fully vaccinated with human
papillomavirus (HPV) vaccine by age 15, 70% of women should be screened with a high-…

Cervical cancer is one of the most common cancers threatening women's health, and the
persistent infection of high-risk human papillomavirus (HPV) is closely related to the …

… efficacy and effectiveness of human papillomavirus vaccination, its potential … of vaccination
for general practitioners and specialists in positions to offer human papillomavirus vaccination …

… or more doses of human papillomavirus vaccine, by sex and … one or more doses of human
papillomavirus vaccine (9.1% in … age at first human papillomavirus vaccine dose among adults …

… The impact of human papillomavirus (HPV) vaccination has been observed in the United
States … To further evaluate vaccine impact, we described trends in HPV vaccine types 16/18 in …

Background The primary goal of human papillomavirus (HPV) vaccination is to reduce morbidity
and mortality from HPV-associated disease, especially cervical cancer. We determined …

… for the nonavalent (9vHPV) vaccine to women and men from … vaccinated discuss the option
with their physician. This review will highlight the history of the vaccine, barriers to vaccination…

… Vaccination against human papillomavirus (HPV) is routinely recommended at age 11 or
12 years. Catch-up recommendations apply to persons not vaccinated at age 11 or 12 years. …